Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2016, Article ID 5830192, 11 pages
http://dx.doi.org/10.1155/2016/5830192
Research Article

Changes in Angiotensin Receptor Distribution and in Aortic Morphology Are Associated with Blood Pressure Control in Aged Metabolic Syndrome Rats

1Department of Physiology, Instituto Nacional de Cardiología “Ignacio Chávez”, 14080 Mexico City, DF, Mexico
2Department of Pathology, Instituto Nacional de Cardiología “Ignacio Chávez”, 14080 Mexico City, DF, Mexico
3National Laboratory of Nanoscience and Nanotechnology, Molecular Biology Division, Instituto Potosino de Investigación Científica y Tecnológica (IPICYT), 78216 San Luis Potosí, SLP, Mexico
4Laboratorio de Nutrición Experimental, Instituto Nacional de Pediatría, 04530 Mexico City, DF, Mexico

Received 4 January 2016; Revised 22 April 2016; Accepted 27 April 2016

Academic Editor: Tomohiro Katsuya

Copyright © 2016 Verónica Guarner-Lans et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. R. Ortlepp, J. Breuer, F. Eitner et al., “Inhibition of the renin-angiotensin system ameliorates genetically determined hyperinsulinemia,” European Journal of Pharmacology, vol. 436, no. 1-2, pp. 145–150, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. R. L. Matz, M. A. de Sotomayor, C. Schott, and R. Andriantsitohaina, “Preservation of vascular contraction during ageing: dual effect on calcium handling and sensitization,” British Journal of Pharmacology, vol. 138, no. 5, pp. 745–750, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. M. E. Rubio, G. Baños, E. Díaz, and V. Guarner, “Effect of age on insulin-induced endothelin release and vasoreactivity in hypertriglyceridemic and hypertensive rats,” Experimental Gerontology, vol. 41, no. 3, pp. 282–288, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. M. E. Rubio-Ruíz, L. Del Valle-Mondragón, V. Castrejón-Tellez, E. Carreón-Torres, E. Díaz-Díaz, and V. Guarner-Lans, “Angiotensin II and 1–7 during aging in metabolic syndrome rats. Expression of AT1, AT2 and Mas receptors in abdominal white adipose tissue,” Peptides, vol. 57, pp. 101–108, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Sysi-Aho, A. Ermolov, P. V. Gopalacharyulu et al., “Metabolic regulation in progression to autoimmune diabetes,” PLoS Computational Biology, vol. 7, no. 10, article e1002257, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. E. L. Santos, K. de Picoli Souza, E. D. da Silva et al., “Long term treatment with ACE inhibitor enalapril decreases body weight gain and increases life span in rats,” Biochemical Pharmacology, vol. 78, no. 8, pp. 951–958, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Benigni, D. Corna, C. Zoja et al., “Disruption of the Ang II type 1 receptor promotes longevity in mice,” The Journal of Clinical Investigation, vol. 119, no. 3, pp. 524–530, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Cassis, S. Conti, G. Remuzzi, and A. Benigni, “Angiotensin receptors as determinants of life span,” Pflugers Archiv European Journal of Physiology, vol. 459, no. 2, pp. 325–332, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. C. A. Aguilar-Salinas, E. García, L. Robles et al., “High adiponectin concentrations are associated with the metabolically healthy obese phenotype,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 10, pp. 4075–4079, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. S. H. S. Santos, J. F. Braga, E. G. Mario et al., “Improved lipid and glucose metabolism in transgenic rats with increased circulating angiotensin-(1-7),” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 5, pp. 953–961, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Engeli, R. Negrel, and A. M. Sharma, “Physiology and pathophysiology of the adipose tissue renin-angiotensin system,” Hypertension, vol. 35, no. 6, pp. 1270–1277, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Wang, Y.-H. Liao, Z. Zhou et al., “Arterial structural changes in rats immunized by AT1-receptor peptide,” Heart and Vessels, vol. 20, no. 4, pp. 153–158, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Barton, R. Carmona, H. Morawietz et al., “Obesity is associated with tissue-specific activation of renal angiotensin-converting enzyme in vivo: evidence for a regulatory role of endothelin,” Hypertension, vol. 35, no. 1, pp. 329–336, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. Q. N. Diep, M. E. Mabrouk, J. S. Cohn et al., “Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-γ,” Circulation, vol. 105, no. 19, pp. 2296–2302, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Xu, A. C. Costa-Goncalves, M. Todiras et al., “Endothelial dysfunction and elevated blood pressure in Mas gene-deleted mice,” Hypertension, vol. 51, no. 2, pp. 574–580, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. R. A. S. Santos, A. J. Ferreira, T. Verano-Braga, and M. Bader, “Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system,” Journal of Endocrinology, vol. 216, no. 2, pp. R1–R17, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. J. E. Jalil, C. Palomera, M. P. Ocaranza et al., “Levels of plasma angiotensin-(1–7) in patients with hypertension who have the angiotensin—I-converting enzyme deletion/deletion genotype,” The American Journal of Cardiology, vol. 92, no. 6, pp. 749–751, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. J. A. Hernández-Prada, A. J. Ferreira, M. J. Katovich et al., “Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents,” Hypertension, vol. 51, no. 5, pp. 1312–1317, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. M. M. Shafaroudi and C. J. Daly, “Endothelial vasodilator angiotensin receptors are changing in mice with ageing,” Research in Molecular Medicine, vol. 2, no. 1, pp. 25–33, 2014. View at Google Scholar
  20. E. J. Henriksen, S. Jacob, T. R. Kinnick, M. K. Teachey, and M. Krekler, “Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats,” Hypertension, vol. 38, no. 4, pp. 884–890, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. W. S. Rasband and J. Image, U. S. National Institutes of Health, Bethesda, Md, USA, 2012, http://imagej.nih.gov/ij/.
  22. N. Charkoudian and J. A. Rabbitts, “Sympathetic neural mechanisms in human cardiovascular health and disease,” Mayo Clinic Proceedings, vol. 84, no. 9, pp. 822–830, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Fukuda, S. Tsuchikura, and H. Iida, “Age-related changes in blood pressure, hematological values, concentrations of serum biochemical constituents and weights of organs in the SHR/Izm, SHRSP/Izm and WKY/Izm,” Experimental Animals, vol. 53, no. 1, pp. 67–72, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Muzumdar, X. Ma, G. Atzmon, P. Vuguin, X. Yang, and N. Barzilai, “Decrease in glucose-stimulated insulin secretion with aging is independent of insulin action,” Diabetes, vol. 53, no. 2, pp. 441–446, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. C. F. Küng and T. F. Lüscher, “Different mechanisms of endothelial dysfunction with aging and hypertension in rat aorta,” Hypertension, vol. 25, no. 2, pp. 194–200, 1995. View at Publisher · View at Google Scholar · View at Scopus
  26. M. El Assar, J. Angulo, S. Vallejo, C. Peiró, C. F. Sánchez-Ferrer, and L. Rodríguez-Mañas, “Mechanisms involved in the aging-induced vascular dysfunction,” Frontiers in Physiology, vol. 3, article 132, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. V. Kotsis, S. Stabouli, I. Karafillis, and P. Nilsson, “Early vascular aging and the role of central blood pressure,” Journal of Hypertension, vol. 29, no. 10, pp. 1847–1853, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. R. P. Brandes, I. Fleming, and R. Busse, “Endothelial aging,” Cardiovascular Research, vol. 66, no. 2, pp. 286–294, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. M. M. Bachschmid, S. Schildknecht, R. Matsui et al., “Vascular aging: chronic oxidative stress and impairment of redox signaling—consequences for vascular homeostasis and disease,” Annals of Medicine, vol. 45, no. 1, pp. 17–36, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. D. A. Long, M. A. Newaz, S. S. Prabhakar et al., “Loss of nitric oxide and endothelial-derived hyperpolarizing factor-mediated responses in aging,” Kidney International, vol. 68, no. 5, pp. 2154–2163, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Csiszar, N. Labinskyy, K. Smith, A. Rivera, Z. Orosz, and Z. Ungvari, “Vasculoprotective effects of anti-tumor necrosis factor-α treatment in aging,” American Journal of Pathology, vol. 170, no. 1, pp. 388–398, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Lähteenvuo and A. Rosenzweig, “Effects of aging on angiogenesis,” Circulation Research, vol. 110, no. 9, pp. 1252–1263, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Matsushita, E. Chang, A. J. Glassford, J. P. Cooke, C.-P. Chiu, and P. S. Tsao, “Activity is reduced in senescent human endothelial cells: preservation by hTERT Immortalization,” Circulation Research, vol. 89, no. 9, pp. 793–798, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Ruiz-Torres, A. Gimeno, J. Melón, L. Mendez, F. J. Muñoz, and M. Macía, “Age-related loss of proliferative activity of human vascular smooth muscle cells in culture,” Mechanisms of Ageing and Development, vol. 110, no. 1-2, pp. 49–55, 1999. View at Publisher · View at Google Scholar · View at Scopus
  35. M. S. Lundberg and M. T. Crow, “Age-related changes in the signaling and function of vascular smooth muscle cells,” Experimental Gerontology, vol. 34, no. 4, pp. 549–557, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Carvajal, A. Velasco, L. H. Martin Arias, and M. Maroto, “Age-related changes in contractile responses to noradrenaline in isolated blood vessels from rat and rabbit,” Journal of Autonomic Pharmacology, vol. 15, no. 5, pp. 321–326, 1995. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Wang, J. Zhang, L.-Q. Jiang et al., “Proinflammatory profile within the grossly normal aged human aortic wall,” Hypertension, vol. 50, no. 1, pp. 219–227, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Shinozaki, K. Ayajiki, Y. Nishio, T. Sugaya, A. Kashiwagi, and T. Okamura, “Evidence for a causal role of the Renin-Angiotensin System in vascular dysfunction associated with insulin resistance,” Hypertension, vol. 43, no. 2 I, pp. 255–262, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. S. P. Bagby, L. S. LeBard, Z. Luo, R. C. Speth, B. E. Ogden, and C. L. Corless, “Angiotensin II type 1 and 2 receptors in conduit arteries of normal developing microswine,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 7, pp. 1113–1121, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Akishita, M. Horiuchi, H. Yamada et al., “Inflammation influences vascular remodeling through AT2 receptor expression and signaling,” Physiological Genomics, vol. 2, no. 1, pp. 13–20, 2000. View at Google Scholar
  41. A. Csiszar, M. Wang, E. G. Lakatta, and Z. Ungvari, “Inflammation and endothelial dysfunction during aging: role of NF-κB,” Journal of Applied Physiology, vol. 105, no. 4, pp. 1333–1341, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Hunyady and K. J. Catt, “Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II,” Molecular Endocrinology, vol. 20, no. 5, pp. 953–970, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Paul, A. P. Mehr, and R. Kreutz, “Physiology of local renin-angiotensin systems,” Physiological Reviews, vol. 86, no. 3, pp. 747–803, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. R. M. Touyz and E. L. Schiffrin, “Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells,” Pharmacological Reviews, vol. 52, no. 4, pp. 639–672, 2000. View at Google Scholar · View at Scopus
  45. G. Gorelik, L. A. Carbini, and A. G. Scicli, “Angiotensin 1–7 induces bradykinin-mediated relaxation in porcine coronary artery,” Journal of Pharmacology and Experimental Therapeutics, vol. 286, no. 1, pp. 403–410, 1998. View at Google Scholar · View at Scopus
  46. R. Soares de Moura, A. C. Resende, A. F. Emiliano et al., “The role of bradykinin, AT2 and angiotensin 1-7 receptors in the EDRF-dependent vasodilator effect of angiotensin II on the isolated mesenteric vascular bed of the rat,” British Journal of Pharmacology, vol. 141, no. 5, pp. 860–866, 2004. View at Publisher · View at Google Scholar · View at Scopus